Class of 2026
For fundamental contributions to precision cancer medicine through pioneering liquid biopsy research in colorectal cancer, uncovering the molecular mechanisms that govern response and resistance to EGFR and HER2 inhibition, and revealing treatment escape driven by increased tumor mutability.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]